Marksans Pharma gets EIR from US FDA for its Goa facility

Read more

Lupin receives FDA approval for generic Corgard Tablets

Read more

Intas Pharma brings down cancer treatment cost by 60%

Read more

SPARC’s Baclofen GRS fails to meet primary end point in placebo controlled studies

Read more

IIT Roorkee scientists identify drug to fight Chikungunya virus

Read more

Granules India gets EIR from USFDA for OmniChem facility

Read more

Novartis divests anti-infectives brands to Samara Capital

Read more

Fosun Pharma acquires 74 per cent stake in Gland Pharma for $1.09 bn

Read more

MoH&FW to introduce new TB drug in controlled manner

Read more

Aptar Pharma to highlight key innovations in drug delivery at CPHI Worldwide

Read more